Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A DAILY pill for the most common form of bladder cancer has been given the green light for NHS use. Erdafitinib, which blocks ...

A twice-daily pill has been approved for use on the NHS that could slow disease progression in cancer patients "in desperate need" of better treatment options. The drug, called capivasertib ...

A PILL which is taken twice a day for the most common type of advanced breast cancer has been approved on the NHS in what scientists say is a “landmark moment”. Up to 3,000 women every ...

A clinical trial that looked into the effects of the new pill plus fulvestrant, a hormone therapy, found that the treatment ...